Posted Aug. 29, 2012 at 5:23 a.m.

Premium Lock Novartis smoker's cough drug beats GSK's Advair in trial

Published: 2012-08-29 05:23:00
Updated: 2012-08-29 05:23:00

Print this blog post
Lung disease Lung disease Image 1 of 2 · Next Image…

Patients taking Novartis's QVA149 were able to expel more air from their lungs in one second than those receiving Glaxo's best-selling Advair after 26 weeks of treatment, according to a summary of data from a trial....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll